Downregulation of ADCY3 and APRT decreases cAMP and AMPK signaling, potentially increasing CRC cell proliferation [56, 58, 59], linking low expression of these genes to poor CRC prognosis. Here, ADCY3 is linked to colorectal carcinoma.